641 related articles for article (PubMed ID: 15215894)
21. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.
Pevny L; Simon MC; Robertson E; Klein WH; Tsai SF; D'Agati V; Orkin SH; Costantini F
Nature; 1991 Jan; 349(6306):257-60. PubMed ID: 1987478
[TBL] [Abstract][Full Text] [Related]
22. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
23. Exploring cellular memory molecules marking competent and active transcriptions.
Xin L; Zhou GL; Song W; Wu XS; Wei GH; Hao DL; Lv X; Liu DP; Liang CC
BMC Mol Biol; 2007 May; 8():31. PubMed ID: 17493269
[TBL] [Abstract][Full Text] [Related]
24. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
[TBL] [Abstract][Full Text] [Related]
25. Expression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expression.
Layon ME; Ackley CJ; West RJ; Lowrey CH
J Mol Biol; 2007 Feb; 366(3):737-44. PubMed ID: 17196618
[TBL] [Abstract][Full Text] [Related]
26. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
27. Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2.
Peters LL; Andrews NC; Eicher EM; Davidson MB; Orkin SH; Lux SE
Nature; 1993 Apr; 362(6422):768-70. PubMed ID: 8469289
[TBL] [Abstract][Full Text] [Related]
28. Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer.
Reddy PM; Shen CK
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8676-80. PubMed ID: 1924329
[TBL] [Abstract][Full Text] [Related]
29. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.
Gong QH; McDowell JC; Dean A
Mol Cell Biol; 1996 Nov; 16(11):6055-64. PubMed ID: 8887635
[TBL] [Abstract][Full Text] [Related]
30. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
[TBL] [Abstract][Full Text] [Related]
31. Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1.
Letting DL; Rakowski C; Weiss MJ; Blobel GA
Mol Cell Biol; 2003 Feb; 23(4):1334-40. PubMed ID: 12556492
[TBL] [Abstract][Full Text] [Related]
32. A WW domain-binding motif within the activation domain of the hematopoietic transcription factor NF-E2 is essential for establishment of a tissue-specific histone modification pattern.
Kiekhaefer CM; Boyer ME; Johnson KD; Bresnick EH
J Biol Chem; 2004 Feb; 279(9):7456-61. PubMed ID: 14597626
[TBL] [Abstract][Full Text] [Related]
33. Genomic footprinting and sequencing of human beta-globin locus. Tissue specificity and cell line artifact.
Reddy PM; Stamatoyannopoulos G; Papayannopoulou T; Shen CK
J Biol Chem; 1994 Mar; 269(11):8287-95. PubMed ID: 8132552
[TBL] [Abstract][Full Text] [Related]
34. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
Armstrong JA; Emerson BM
Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
[TBL] [Abstract][Full Text] [Related]
35. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
[TBL] [Abstract][Full Text] [Related]
36. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin.
Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E
Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316
[TBL] [Abstract][Full Text] [Related]
37. Identification of GATA-1 and NF-E2 binding sites in the flanking regions of the human alpha-globin genes.
Gourdon G; Morlé F; Roche J; Tourneur N; Joulain V; Godet J
Acta Haematol; 1992; 87(3):136-44. PubMed ID: 1642094
[TBL] [Abstract][Full Text] [Related]
38. The distinctive roles of erythroid specific activator GATA-1 and NF-E2 in transcription of the human fetal γ-globin genes.
Woon Kim Y; Kim S; Geun Kim C; Kim A
Nucleic Acids Res; 2011 Sep; 39(16):6944-55. PubMed ID: 21609963
[TBL] [Abstract][Full Text] [Related]
39. Dissecting molecular steps in chromatin domain activation during hematopoietic differentiation.
Kim SI; Bultman SJ; Jing H; Blobel GA; Bresnick EH
Mol Cell Biol; 2007 Jun; 27(12):4551-65. PubMed ID: 17438135
[TBL] [Abstract][Full Text] [Related]
40. GATA transcription factors associate with a novel class of nuclear bodies in erythroblasts and megakaryocytes.
Elefanty AG; Antoniou M; Custodio N; Carmo-Fonseca M; Grosveld FG
EMBO J; 1996 Jan; 15(2):319-33. PubMed ID: 8617207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
